France Leads World In Homeopathy

26 May 1996

Worldwide sales of homeopathic drug products are estimated at some 6 billion French francs ($1.15 billion), and France alone now accounts for sales of 1.5 billion francs.

Boiron is market leader with 60%, followed by Dolisos with an estimated 25% and Lehning with 5%. These firms report constantly rising sales, increasing from 500 million francs in 1982 to 1.6 billion francs in 1993, or 2.2% of the French drug market compared with 1.2% of the European and 1% of the world market.

A new survey of the sector by Ifop is now underway, but the last poll, in 1994, showed that 75% of the public said they were in favor of homeopathy.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight